DOM-ISMN 60 MG
ISOSORBIDE-5-MONONITRATE : 60 MG · DIN 02307758 · DOMINION PHARMACAL
Health Canada status: CANCELLED PRE MARKET
What is DOM-ISMN?
DOM-ISMN 60 MG contains ISOSORBIDE-5-MONONITRATE : 60 MG. It is listed in the Health Canada Drug Product Database under DIN 02307758, held by DOMINION PHARMACAL, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 13-Aug-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02307758 |
|---|---|
| Brand name | DOM-ISMN |
| Generic / active ingredient | ISOSORBIDE-5-MONONITRATE : 60 MG |
| Manufacturer | DOMINION PHARMACAL |
| Strength | 60 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Ethical |
| ATC code | C01DA14 ISOSORBIDE MONONITRATE |
| AHFS class | 24:12.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 13-Aug-2025 |
What can be used instead?
Other Canadian products sharing ATC code C01DA14 ISOSORBIDE MONONITRATE. 3 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ISMN | 60 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02272830 |
| PMS-ISMN | 60 MG | TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED | DIN 02301288 |
| PRO-ISMN - 60 | 60 MG | TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | MARKETED | DIN 02311321 |
| IMDUR | 60 MG | TABLET (EXTENDED-RELEASE) | JUNO PHARMACEUTICALS CORP. | DORMANT | DIN 02126559 |
| ISMN | 60 MG | TABLET (EXTENDED-RELEASE) | SIVEM PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02446073 |
| ISMO TAB 20MG | 20 MG | TABLET | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02058472 |
| PHL-ISMN | 60 MG | TABLET (EXTENDED-RELEASE) | PHARMEL INC | CANCELLED PRE MARKET | DIN 02307731 |
Who else supplies ISOSORBIDE MONONITRATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ISOSORBIDE MONONITRATE appears in 2801 registered pack listings across 13 markets, published on 12 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.